KSPC Launches India First VR Pharma Training for Students

By introducing the Virtual Simulation-based Pharmaceutical Manufacturing Training Program, which is exclusive for pharmacy students, the Karnataka State Pharmacy Council (KSPC) has made a major advancement in pharmacy education

Asahi Kasei Advances Research to Ease Chemotherapy Nerve Symptoms

In a Phase III research of ART-123, Asahi Kasei Pharma has begun trial drug administration in Japan to avoid symptoms associated with chemotherapy-induced peripheral neuropathy. This statement comes after positive results from previous Phase I and II

Telangana Aims to Be India's Leading Health Tourism Destination

Telangana Chief Minister A. Revanth Reddy has rolled out an ambitious proposal to make Telangana the foremost state in India as a health tourism State. In his remarks during the launch...

IPA Defends COVID-19 Vaccine Safety Amid Karnataka Allegations

In a recent response to the reports in Karnataka's Hassan district claiming COVID-19 vaccines led to heart attack deaths, the Indian Pharmaceutical Alliance (IPA) expressed its strong defense of both vaccine safety and the integrity of regulatory...

NCAHP Proposes Replacing 'Paramedical' with 'Allied & Healthcare'

In the most significant move towards the standardization of language across the Indian healthcare system, the National Commission for Allied and Healthcare Professions (NCAHP) set up by the Union Health Ministry

Alembic Pharma Buys UK's Utility Therapeutics for USD 12 Million

Alembic Pharmaceuticals has entered into a definitive agreement to acquire UK-based Utility Therapeutics Ltd. for USD 12 million, a strategic expansion into the branded anti-infective space in the United States...

Delhi HC Seeks Clarity on Ozempic, Mounjaro Approvals Amid Safety Concerns

In a major development for India's drug regulatory system, the Delhi High Court has ordered the Drug Controller General of India (DCGI) to respond within three months to a Public Interest Litigation (PIL) that challenges the approval of...

India's Pharma Exports Surge to 4.96 Billion USD in April-May 2025

The Indian pharmaceutical industry achieved a worthwhile of 7.38 with April-May FY26, which recorded $4.961 billion in Indian pharmaceutical exports compared to the same period in FY25, showing a healthy growth rate, as reported by Pharmex...

Lyfius Pharma Resumes Penicillin-G Production in Kakinada Plant

Lyfius Pharma Private Limited, a fully owned step-down subsidiary of Aurobindo Pharma, has announced the resumption of production at its Penicillin-G manufacturing facility in Kakinada, Andhra Pradesh

Cadila Pharma Launches Bilacad Dex Syrup for Allergy Relief

Cadila Pharmaceuticals has launched Bilacad Dex Syrup, a fixed-dose combination for meeting the mounting burden of respiratory and allergic conditions.

on the deck


Most Viewed

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.